Inventor

WRIGHT MARTIN C

US22 patents

⚠️ This page may combine multiple inventors who share the name “WRIGHT MARTIN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WRIGHT MARTIN C

BRISTOL MYERS SQUIBB CO

Inhibitors of type 2 vascular endothelial growth factor receptors

Pharmacokinetic modulation and compositions for modified FN3 polypeptides

Inhibitors of type 2 vascular endothelial growth factor receptors

Bispecific EGFR/IGFIR binding molecules

Bispecific EGFR/IGFIR binding molecules

Inhibitors of type 2 vascular endothelial growth factor receptors

Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules

PD-L1 binding polypeptides for imaging

Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules

Methods of treating cancer by administering IGF-IR binding molecules

Libraries of modified fibronectin type III tenth domain-containing polypeptides

Bispecific EGFR/IGFIR binding molecules

PET imaging with PD-L1 binding polypeptides

PD-L1 binding polypeptides for imaging

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

PD-L1 binding polypeptides for imaging

CHEN YAN

Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides

Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors

PHYLOS INC

Methods for generating highly diverse libraries

Methods for producing 5′-nucleic acid-protein conjugates

CAMPHAUSEN RAY

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

BASF AG

Isolated promoter and terminator of elongation factor 1-α